1. Product
Overview
2. Research
Methodology
3. Executive
Summary
4. Impact
of COVID-19 on Global Natural Killer Cells Therapeutics Market
5. Voice
of Customer
6. Clinical
Trial Analysis
7.
Global Natural Killer Cells Therapeutics
Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1.
By
Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed
Antibodies)
7.2.2.
By
Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders,
Others)
7.2.3.
By End
User (Hospitals & Clinics, Academic & Research Institutions, Others)
7.2.4.
By
Region
7.2.5. By
Company (2021)
7.3. Market
Map
8.
North America Natural Killer Cells
Therapeutics Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1.
By
Type
8.2.2.
By
Application
8.2.3.
By End
User
8.2.4. By
Country
8.3. North
America: Country Analysis
8.3.1. United
States Natural Killer Cells Therapeutics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Application
8.3.1.2.3.
By End User
8.3.2. Canada
Natural Killer Cells Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Application
8.3.2.2.3.
By End User
8.3.3. Mexico
Natural Killer Cells Therapeutics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Application
8.3.3.2.3.
By End User
9.
Europe Natural Killer Cells Therapeutics
Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1.
By
Type
9.2.2.
By
Application
9.2.3.
By End
User
9.2.4.
By
Country
9.3. Europe:
Country Analysis
9.3.1. France
Natural Killer Cells Therapeutics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Application
9.3.1.2.3.
By End User
9.3.2. Germany
Natural Killer Cells Therapeutics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Application
9.3.2.2.3.
By End User
9.3.3. United
Kingdom Natural Killer Cells Therapeutics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Application
9.3.3.2.3.
By End User
9.3.4. Italy
Natural Killer Cells Therapeutics Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Type
9.3.4.2.2.
By Application
9.3.4.2.3.
By End User
9.3.5. Spain
Natural Killer Cells Therapeutics Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Type
9.3.5.2.2.
By Application
9.3.5.2.3.
By End User
10. Asia-Pacific
Natural Killer Cells Therapeutics Market Outlook
10.1.
Market Size & Forecast
10.1.1. By
Value
10.2.
Market Share & Forecast
10.2.1.
By
Type
10.2.2.
By Application
10.2.3.
By End
User
10.2.4. By
Country
10.3.
Asia-Pacific: Country Analysis
10.3.1. China
Natural Killer Cells Therapeutics Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Application
10.3.1.2.3.
By End User
10.3.2. India
Natural Killer Cells Therapeutics Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Application
10.3.2.2.3.
By End User
10.3.3. Japan
Natural Killer Cells Therapeutics Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Application
10.3.3.2.3.
By End User
10.3.4. South
Korea Natural Killer Cells Therapeutics Market Outlook
10.3.4.1. Market
Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market
Share & Forecast
10.3.4.2.1.
By Type
10.3.4.2.2.
By Application
10.3.4.2.3.
By End User
10.3.5. Australia
Natural Killer Cells Therapeutics Market Outlook
10.3.5.1. Market
Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2. Market
Share & Forecast
10.3.5.2.1.
By Type
10.3.5.2.2.
By Application
10.3.5.2.3.
By End User
11. South
America Natural Killer Cells Therapeutics Market Outlook
11.1.
Market Size & Forecast
11.1.1. By
Value
11.2.
Market Share & Forecast
11.2.1.
By
Type
11.2.2.
By
Application
11.2.3.
By End
User
11.2.4. By
Country
11.3.
South America: Country Analysis
11.3.1. Brazil
Natural Killer Cells Therapeutics Market Outlook
11.3.1.1. Market
Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market
Share & Forecast
11.3.1.2.1.
By Type
11.3.1.2.2.
By Application
11.3.1.2.3.
By End User
11.3.2. Argentina
Natural Killer Cells Therapeutics Market Outlook
11.3.2.1. Market
Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market
Share & Forecast
11.3.2.2.1.
By Type
11.3.2.2.2.
By Application
11.3.2.2.3.
By End User
11.3.3. Colombia
Natural Killer Cells Therapeutics Market Outlook
11.3.3.1. Market
Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market
Share & Forecast
11.3.3.2.1.
By Type
11.3.3.2.2.
By Application
11.3.3.2.3.
By End User
12. Middle
East and Africa Natural Killer Cells Therapeutics Market Outlook
12.1.
Market Size & Forecast
12.1.1. By
Value
12.2.
Market Share & Forecast
12.2.1.
By
Type
12.2.2.
By
Application
12.2.3.
By End
User
12.2.4. By
Country
12.3.
MEA: Country Analysis
12.3.1. South
Africa Natural Killer Cells Therapeutics Market Outlook
12.3.1.1. Market
Size & Forecast
12.3.1.1.1.
By Value
12.3.1.2. Market
Share & Forecast
12.3.1.2.1.
By Type
12.3.1.2.2.
By Application
12.3.1.2.3.
By End User
12.3.2. Saudi
Arabia Natural Killer Cells Therapeutics Market Outlook
12.3.2.1. Market
Size & Forecast
12.3.2.1.1.
By Value
12.3.2.2. Market
Share & Forecast
12.3.2.2.1.
By Type
12.3.2.2.2.
By Application
12.3.2.2.3.
By End User
12.3.3. UAE
Natural Killer Cells Therapeutics Market Outlook
12.3.3.1. Market
Size & Forecast
12.3.3.1.1.
By Value
12.3.3.2. Market
Share & Forecast
12.3.3.2.1.
By Type
12.3.3.2.2.
By Application
12.3.3.2.3.
By End User
12.3.4. Turkey
Natural Killer Cells Therapeutics Market Outlook
12.3.4.1. Market
Size & Forecast
12.3.4.1.1.
By Value
12.3.4.2. Market
Share & Forecast
12.3.4.2.1.
By Type
12.3.4.2.2.
By Application
12.3.4.2.3.
By End User
12.3.5. Egypt
Natural Killer Cells Therapeutics Market Outlook
12.3.5.1. Market
Size & Forecast
12.3.5.1.1.
By Value
12.3.5.2. Market
Share & Forecast
12.3.5.2.1.
By Type
12.3.5.2.2.
By Application
12.3.5.2.3.
By End User
13. Market
Dynamics
13.1.
Drivers
13.2.
Challenges
14. Market
Trends & Developments
15. Competitive
Landscape
15.1.
Affimed N.V.
15.2.
Century Therapeutics, Inc.
15.3.
Celularity Inc.
15.4.
Cytovac A/S
15.5.
Dragonfly Therapeutics, Inc.
15.6.
Fate Therapeutics, Inc.
15.7.
Gamida Cell Ltd.
15.8.
ImmunityBio, Inc.
15.9.
Innate Pharma SA
15.10.
Nkarta, Inc.
15.11.
Sanofi S.A.
15.12.
Takeda Pharmaceutical Company Limited
15.13.
VaxCell Biotherapeutics Co., Ltd.
15.14.
Acepodia Inc.
15.15.
Glycostem Therapeutics B.V.
16. Strategic
Recommendations